JESSICA CHAVARRIA: Open Payments
NPI 1356866297 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$261 in 11 payments from 9 companies in 2025. Trend: 2023 $446 · 2024 $307 · 2025 $261
Food & beverage: $261
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $44 |
| Neurocrine BioSciences, Inc. | 1 | $36 |
| Vanda Pharmaceuticals Inc. | 1 | $36 |
| Lundbeck LLC | 2 | $33 |
| Lilly USA, LLC | 1 | $26 |
| Novo Nordisk Inc | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| ALK-Abello, Inc | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
Products named: REXULTI, QULIPTA, INGREZZA, HETLIOZ, MOUNJARO, Odactra, Cologuard Collection Kit.
Industry payments across VA — which companies pay providers there.
